The results of this study indicated that large total BTS and high NLR were independent negative predictors of OS in patients with ES-SCLC or post-chemoradiotherapy recurrence of limited-stage SCLC treated with chemotherapy plus PD-L1 inhibitor as first-line therapy. Here, CD274 is linked to small cell lung carcinoma.